Methazolamide: Difference between revisions

Jump to navigation Jump to search
m (Protected "Methazolamide": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
m (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
Line 27: Line 27:


{{SI}}
{{SI}}
{{EH}}
 


'''Methazolamide (Neptazane®)''' is a [[carbonic anhydrase]] inhibitor.
'''Methazolamide (Neptazane®)''' is a [[carbonic anhydrase]] inhibitor.
Line 38: Line 38:


{{Antiglaucoma preparations and miotics}}
{{Antiglaucoma preparations and miotics}}
{{SIB}}
 
[[Category:Carbonic anhydrase inhibitors]]
[[Category:Carbonic anhydrase inhibitors]]
{{WH}}
{{WH}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Revision as of 17:22, 9 August 2012

Methazolamide
Clinical data
Pregnancy
category
  • US: C (Risk not ruled out)
Routes of
administration
Oral
ATC code
Legal status
Legal status
Pharmacokinetic data
Protein binding55%
Elimination half-life14 hours
Identifiers
CAS Number
PubChem CID
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC5H8N4O3S2
Molar mass236.274 g/mol

WikiDoc Resources for Methazolamide

Articles

Most recent articles on Methazolamide

Most cited articles on Methazolamide

Review articles on Methazolamide

Articles on Methazolamide in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Methazolamide

Images of Methazolamide

Photos of Methazolamide

Podcasts & MP3s on Methazolamide

Videos on Methazolamide

Evidence Based Medicine

Cochrane Collaboration on Methazolamide

Bandolier on Methazolamide

TRIP on Methazolamide

Clinical Trials

Ongoing Trials on Methazolamide at Clinical Trials.gov

Trial results on Methazolamide

Clinical Trials on Methazolamide at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Methazolamide

NICE Guidance on Methazolamide

NHS PRODIGY Guidance

FDA on Methazolamide

CDC on Methazolamide

Books

Books on Methazolamide

News

Methazolamide in the news

Be alerted to news on Methazolamide

News trends on Methazolamide

Commentary

Blogs on Methazolamide

Definitions

Definitions of Methazolamide

Patient Resources / Community

Patient resources on Methazolamide

Discussion groups on Methazolamide

Patient Handouts on Methazolamide

Directions to Hospitals Treating Methazolamide

Risk calculators and risk factors for Methazolamide

Healthcare Provider Resources

Symptoms of Methazolamide

Causes & Risk Factors for Methazolamide

Diagnostic studies for Methazolamide

Treatment of Methazolamide

Continuing Medical Education (CME)

CME Programs on Methazolamide

International

Methazolamide en Espanol

Methazolamide en Francais

Business

Methazolamide in the Marketplace

Patents on Methazolamide

Experimental / Informatics

List of terms related to Methazolamide


Methazolamide (Neptazane®) is a carbonic anhydrase inhibitor.

References

  • Iyer G, Bellantone R, Taft D (1999). "In vitro characterization of the erythrocyte distribution of methazolamide: a model of erythrocyte transport and binding kinetics". J Pharmacokinet Biopharm. 27 (1): 45–66. PMID 10533697.
  • RxList. "Neptazane". Unknown parameter |accessyear= ignored (|access-date= suggested) (help); Unknown parameter |accessmonthday= ignored (help)
  • Shirato S, Kagaya F, Suzuki Y, Joukou S (1997). "Stevens-Johnson syndrome induced by methazolamide treatment". Arch Ophthalmol. 115 (4): 550–3. PMID 9109770.
  • Skorobohach B, Ward D, Hendrix D (2003). "Effects of oral administration of methazolamide on intraocular pressure and aqueous humor flow rate in clinically normal dogs". Am J Vet Res. 64 (2): 183–7. PMID 12602587.

Template:Antiglaucoma preparations and miotics Template:WH Template:WikiDoc Sources